Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Gains 10%; BSE HEALTHCARE Index Up 0.5%
Tue, 24 Sep 9:45

ASTRAZENECA PHARMA Gains 10%; BSE HEALTHCARE Index Up 0.5%Image source: Nikada/www.istockphoto.com

ASTRAZENECA PHARMA share price has zoomed 10% and is presently trading at Rs 7,444.0.

Meanwhile, the BSE HEALTHCARE index is at 44,459.9 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (up 4.4%) and IPCA Labs (up 1.9%).

LAURUS LABS (down 1.1%) and ALEMBIC PHARMA (down 1.1%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 4,503.9 to Rs 7,444.0, registering a gain of Rs 2,940.1 (up 65.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,349.9 to 44,459.9, registering a gain of 56.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 177.9%), SUVEN PHARMACEUTICALS (up 128.8%) and Glenmark Pharma (up 99.7%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 84,916.7 .

The top losers among the BSE Sensex today are Bajaj Finance (down 1.4%) and Hindustan Unilever (down 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,936.8 . Bajaj Finance and Hindustan Unilever are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,800.8 to 84,916.7, registering a gain of 18,115.8 points (up 27.1%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit fell 121.9% YoY to Rs -118 million for the quarter ended June 2024, compared to a profit of Rs 539 million a year ago. Net sales rose 31.2% to Rs 3,875 million during the period as against Rs 2,955 million in April-June 2023.

For the year ended March 2024, ASTRAZENECA PHARMA reported 62.7% increase in net profit to Rs 1,615 million compared to net profit of Rs 993 million during FY23. Revenue of the company grew 29.2% to Rs 12,955 million during FY24.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 194.1.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Gains 10%; BSE HEALTHCARE Index Up 0.5%". Click here!